top of page

Evidence-Based Innovation

Advancing the Science of Healing

Our field is dedicated to the highest standards of clinical data and curated research. May we bridge the gap between ancient wisdom and modern rigorous evidence to redefine mental health care through psychedelic-assisted psychotherapy.

1000052579.jpg
Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective Outcomes

This review underscores the critical role of music in shaping psychedelic experiences and therapeutic outcomes.

Document.pdf
OIP (1).webp

Human Brain Changes After First Psilocybin Use

2026. Increases in cognitive flexibility, psychological insight, and well-being are seen at one-month. 

Document.pdf
MAPP1-Infographic1.webp
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial

MDMA-assisted therapy provides highly effective treatment for PTSD, showing significant safety and clinical benefits.

Document.pdf
MAPS summary

Research & Articles

41591_2026_4287_Fig1_HTML.webp
An international mega-analysis of psychedelic drug effects on brain circuit function

This study provides the most comprehensive synthesis of psychedelic brain action to date (2026)

Document.pdf
The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world

Scale to measure connectedness to self, others, and the wider world, especially before and after psychedelic therapy. 

Document.pdf

How Psychedelics Affect the Brain

​

Ongoing experimental research is exploring how psychedelics like psilocybin affect the brain and how they could serve as a potential treatment for brain and mental health disorders. Based on a recent study, a controlled dose of psilocybin may have therapeutic effects for relieving mental health conditions like depression, anxiety, and post-traumatic stress disorder (PTSD).

Read More

71%

Clinical Success

Participants showing significant reduction in PTSD symptoms after three sessions of MDMA-assisted therapy in phase 3 trials.

12mo

Sustained Healing

Follow-up data indicates that clinical improvements remain stable for at least one year following the treatment protocol.

85%

Therapeutic Alliance

High scores in patient-reported therapeutic alliance, correlating with the deep relational work facilitated by psychedelics.

They offer a  free and extensive library of articles from health professionals and the psychedelic community!
Library
bottom of page